Cargando…
ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients
OBJECTIVE: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). METHODS: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792028/ https://www.ncbi.nlm.nih.gov/pubmed/24116229 http://dx.doi.org/10.1371/journal.pone.0077432 |
_version_ | 1782286787612246016 |
---|---|
author | D’Archivio, Massimo Scazzocchio, Beatrice Giammarioli, Stefania Fiani, Maria L. Varì, Rosaria Santangelo, Carmela Veneziani, Augusto Iacovelli, Annunziata Giovannini, Claudio Gessani, Sandra Masella, Roberta |
author_facet | D’Archivio, Massimo Scazzocchio, Beatrice Giammarioli, Stefania Fiani, Maria L. Varì, Rosaria Santangelo, Carmela Veneziani, Augusto Iacovelli, Annunziata Giovannini, Claudio Gessani, Sandra Masella, Roberta |
author_sort | D’Archivio, Massimo |
collection | PubMed |
description | OBJECTIVE: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). METHODS: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m(2)) and over-weight/obese (BMI 26.0-40.0 Kg/m(2)), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPARγ transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the ω3 docosahexaenoic acid treatment on the balance between pro- and anti-inflammatory factors in adipocytes was also evaluated. RESULTS: We provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPARγ and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased ω3-/ω6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPARγ. CONCLUSION: Our results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies. |
format | Online Article Text |
id | pubmed-3792028 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-37920282013-10-10 ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients D’Archivio, Massimo Scazzocchio, Beatrice Giammarioli, Stefania Fiani, Maria L. Varì, Rosaria Santangelo, Carmela Veneziani, Augusto Iacovelli, Annunziata Giovannini, Claudio Gessani, Sandra Masella, Roberta PLoS One Research Article OBJECTIVE: The aim of this study was to correlate specific fatty acid profiles of visceral white adipose tissue (WAT) with inflammatory signatures potentially associated with colorectal cancer (CRC). METHODS: Human adipocytes were isolated from biopsies of visceral WAT from 24 subjects subdivided in four groups: normal-weight (BMI 22.0-24.9 Kg/m(2)) and over-weight/obese (BMI 26.0-40.0 Kg/m(2)), affected or not by CRC. To define whether obesity and/or CRC affect the inflammatory status of WAT, the activation of the pro-inflammatory STAT3 and the anti-inflammatory PPARγ transcription factors as well as the expression of adiponectin were analyzed by immunoblotting in adipocytes isolated from each group of subjects. Furthermore, to evaluate whether differences in inflammatory WAT environment correlate with specific fatty acid profiles, gas-chromatographic analysis was carried out on WAT collected from all subject categories. Finally, the effect of the ω3 docosahexaenoic acid treatment on the balance between pro- and anti-inflammatory factors in adipocytes was also evaluated. RESULTS: We provide the first evidence for the existence of a pro-inflammatory environment in WAT of CRC patients, as assessed by the up-regulation of STAT3, and the concomitant decrease of PPARγ and adiponectin with respect to healthy subjects. WAT inflammatory status was independent of obesity degree but correlated with a decreased ω3-/ω6-polyunsaturated fatty acid ratio. These observations suggested that qualitative changes, other than quantitative ones, in WAT fatty acid may influence tissue dysfunctions potentially linked to inflammatory conditions. This hypothesis was further supported by the finding that adipocyte treatment with docosahexaenoic acid restored the equilibrium between STAT3 and PPARγ. CONCLUSION: Our results suggest that adipocyte dysfunctions occur in CRC patients creating a pro-inflammatory environment that might influence cancer development. Furthermore, the protective potential of docosahexaenoic acid in re-establishing the equilibrium between pro- and anti-inflammatory factors might represent a useful tool for preventive and therapeutic strategies. Public Library of Science 2013-10-07 /pmc/articles/PMC3792028/ /pubmed/24116229 http://dx.doi.org/10.1371/journal.pone.0077432 Text en © 2013 D'Archivio et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article D’Archivio, Massimo Scazzocchio, Beatrice Giammarioli, Stefania Fiani, Maria L. Varì, Rosaria Santangelo, Carmela Veneziani, Augusto Iacovelli, Annunziata Giovannini, Claudio Gessani, Sandra Masella, Roberta ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients |
title | ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients |
title_full | ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients |
title_fullStr | ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients |
title_full_unstemmed | ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients |
title_short | ω3-PUFAs Exert Anti-Inflammatory Activity in Visceral Adipocytes from Colorectal Cancer Patients |
title_sort | ω3-pufas exert anti-inflammatory activity in visceral adipocytes from colorectal cancer patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792028/ https://www.ncbi.nlm.nih.gov/pubmed/24116229 http://dx.doi.org/10.1371/journal.pone.0077432 |
work_keys_str_mv | AT darchiviomassimo ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT scazzocchiobeatrice ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT giammariolistefania ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT fianimarial ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT varirosaria ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT santangelocarmela ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT venezianiaugusto ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT iacovelliannunziata ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT giovanniniclaudio ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT gessanisandra ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients AT masellaroberta ō3pufasexertantiinflammatoryactivityinvisceraladipocytesfromcolorectalcancerpatients |